• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Duration of first-line chemotherapy in advanced non small-cell lung cancer: less is more in the era of effective subsequent therapies.

作者信息

Socinski Mark A, Stinchcombe Thomas E

出版信息

J Clin Oncol. 2007 Nov 20;25(33):5155-7. doi: 10.1200/JCO.2007.13.4015.

DOI:10.1200/JCO.2007.13.4015
PMID:18024862
Abstract
摘要

相似文献

1
Duration of first-line chemotherapy in advanced non small-cell lung cancer: less is more in the era of effective subsequent therapies.晚期非小细胞肺癌一线化疗的疗程：在有有效后续治疗手段的时代，疗程越短越好。
J Clin Oncol. 2007 Nov 20;25(33):5155-7. doi: 10.1200/JCO.2007.13.4015.
2
[Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].[IV期非小细胞肺癌。转移性非小细胞肺癌的二线治疗]
Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S113-8.
3
Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?重新评估晚期非小细胞肺癌的治疗时长：这真的只是关于时长，还是更多关乎时机和暴露情况？
J Clin Oncol. 2009 Jul 10;27(20):3268-70. doi: 10.1200/JCO.2009.22.4345. Epub 2009 May 26.
4
Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?非小细胞肺癌的辅助化疗：效果渐失？
J Clin Oncol. 2008 Nov 1;26(31):5014-7. doi: 10.1200/JCO.2008.18.1081. Epub 2008 Sep 22.
5
Refining prognosis in non-small-cell lung cancer.优化非小细胞肺癌的预后评估
N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1.
6
Chemotherapy for lung cancer: the state of the art in 2009.肺癌化疗：2009年的最新进展
Expert Rev Anticancer Ther. 2009 Oct;9(10):1365-78. doi: 10.1586/era.09.115.
7
Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapies.老年晚期非小细胞肺癌的治疗：从最佳支持治疗到铂类化疗与靶向治疗联合应用
J Clin Oncol. 2008 Jan 1;26(1):13-5. doi: 10.1200/JCO.2007.14.1820.
8
Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.在初治的晚期或转移性非小细胞肺癌患者中比较贝沙罗汀（L1069-49）/顺铂/长春瑞滨与顺铂/长春瑞滨的随机III期试验：SPIRIT I
J Clin Oncol. 2008 Apr 10;26(11):1886-92. doi: 10.1200/JCO.2007.12.2614.
9
Lung cancer staging techniques and induction therapy: maybe timing is everything.肺癌分期技术与诱导治疗：或许时机就是一切。
J Clin Oncol. 2008 Jul 10;26(20):3306-7. doi: 10.1200/JCO.2008.16.5258. Epub 2008 Jun 2.
10
Therapeutic options for elderly patients with advanced non-small cell lung cancer.老年晚期非小细胞肺癌患者的治疗选择
Cancer Treat Rev. 2009 Jun;35(4):340-4. doi: 10.1016/j.ctrv.2008.10.008. Epub 2009 Jan 19.

引用本文的文献

1
Controlling Cumulative Adverse Risk in Learning Optimal Dynamic Treatment Regimens.学习最优动态治疗方案中的累积不良风险控制
J Am Stat Assoc. 2024;119(548):2622-2633. doi: 10.1080/01621459.2023.2270637. Epub 2023 Dec 11.
2
Constructing dynamic treatment regimes with shared parameters for censored data.为删失数据构建具有共享参数的动态治疗方案。
Stat Med. 2020 Apr 30;39(9):1250-1263. doi: 10.1002/sim.8473. Epub 2020 Jan 17.
3
New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.用于估计最优动态治疗方案的新统计学习方法。
J Am Stat Assoc. 2015;110(510):583-598. doi: 10.1080/01621459.2014.937488.
4
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.发音：一项随机、开放标签的III期研究，比较一线培美曲塞+卡铂序贯培美曲塞维持治疗与紫杉醇+卡铂+贝伐单抗序贯贝伐单抗维持治疗在晚期非鳞状非小细胞肺癌患者中的疗效。 （注：原文中“ith”应改为“with”）
J Thorac Oncol. 2015 Jan;10(1):134-42. doi: 10.1097/JTO.0000000000000366.
5
Consolidation chemotherapy with docetaxel after platinum-based chemotherapy in patients with non-small cell lung cancer: a preliminary report.多西他赛用于非小细胞肺癌患者铂类化疗后的巩固化疗：初步报告
Tanaffos. 2011;10(3):20-3.
6
Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.可切除胃癌患者基于氟尿嘧啶的辅助化疗的最佳持续时间。
PLoS One. 2013 Dec 26;8(12):e83196. doi: 10.1371/journal.pone.0083196. eCollection 2013.
7
Recent development on statistical methods for personalized medicine discovery.个性化医学发现的统计方法的最新进展。
Front Med. 2013 Mar;7(1):102-10. doi: 10.1007/s11684-013-0245-7. Epub 2013 Feb 2.
8
Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer.非小细胞肺癌临床试验的强化学习策略
Biometrics. 2011 Dec;67(4):1422-33. doi: 10.1111/j.1541-0420.2011.01572.x. Epub 2011 Mar 8.
9
Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.西妥昔单抗治疗晚期非小细胞肺癌的合理应用。
Onco Targets Ther. 2009 Feb 18;2:251-60. doi: 10.2147/ott.s4761.
10
Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.非小细胞肺癌的最新进展——美国临床肿瘤学会 2009 年第 45 届年会的研究成果。
J Hematol Oncol. 2010 May 2;3:18. doi: 10.1186/1756-8722-3-18.